NCT05656651Active, not recruitingPhase 2
Acute Immunological Effects of Exercise in Cancer Patients
ACTIVE- Acute Effects of a Single Physical Exercise Intervention on Immune Cells and Inflammation in Cancer Patients and a Healthy Comparison Group
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
The aim of the study is to evaluate and compare immune response to a single exercise intervention in cancer patients and healthy age-maged individuals.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 13 Nov 2022
- Start date
- 19 Dec 2022
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- Universität Duisburg-Essen
- Diseases
- Childhood cancers
- NCT number
- NCT05656651
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 60
- From 19 Dec 2022 to the primary completion date, 31 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- chemotherapeutic treatment 48 h prior
Lab values
- Hb \<8g/dl; platelets \< 20,000/ul.
Other
- Inability to follow and implement test instructions
- medical contraindication to HIIT on cycle ergometer
Who the study is looking for
- Adolescents and young adults \>14 years of age
- undergoing acute cancer treatment (chemotherapy)
- signed informed consent
Age in the registry: 15 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Essen Coordinator of this site? Confirm its status | Essen | Germany | Unknown status |
Related publications
- High-Intensity Interval Training Boosts Immune Cells in Advanced Cancer Patients and Healthy Controls: Implications for Cancer Care.Cancer Med · 2026 · PMID 42233178
This page is information, not medical advice. Discuss any trial with your doctor.